🚨 90,000 Bottles of Children’s Ibuprofen Recalled Over Contamination Concerns

Consumers reported ‘gel-like mass and black particles’ in Children’s Ibuprofen Oral Suspension

4

Washington, D.C. — Nearly 90,000 bottles of children’s pain medication have been recalled in the United States after reports of contamination, according to the U.S. Food and Drug Administration.

The recall involves Children’s Ibuprofen Oral Suspension distributed by Taro Pharmaceuticals, commonly used to treat pain and fever in children ages 2 to 11.

⚠️ Reports of Contamination

The FDA said the recall was triggered after consumers reported finding “gel-like mass and black particles” in the liquid medication.

Officials warn that the presence of foreign material could pose potential health risks, particularly for young children.

📦 Affected Products

The recall applies to:

• Lot numbers: 261973A and 7261974A
• Expiration date: January 31, 2027
• Form: Berry-flavored liquid ibuprofen for children

Consumers are advised to stop using the product immediately and seek medical advice if any adverse effects occur.

🏭 Manufacturing Details

The medication was manufactured in India by Strides Pharma Inc., a company that produces generic and over-the-counter medicines for global markets.

The recall was initiated by the manufacturer and later announced by the FDA.

🩺 Recall Classification

The FDA has classified the recall as a Class II recall, meaning the product may cause temporary or medically reversible health effects, while the risk of serious harm is considered low.

🔍 Ongoing Monitoring

Health authorities continue to monitor the situation and encourage consumers to report any issues related to the recalled medication.